Back

Higher SARS-CoV-2 Transmission Burden Among Racialized Individuals: Evidence from Canadian Serology Data

Mann, S. K.; Wilson, N. J.; Lee, C. E.; Fisman, D.

2026-03-25 infectious diseases
10.64898/2026.03.23.26349092 medRxiv
Show abstract

Introduction: COVID-19 transmission has not been evenly distributed across racial groups, with exposure being shaped by social and structural factors. The emergence of highly transmissible variants (i.e., Omicron) dramatically increased infection rates. However, it remains unclear whether racial disparities in transmission disappeared or persisted over the course of the pandemic. Objective: To understand how SARS-CoV-2 transmission differed by race in Canada and whether those disparities changed with the Omicron variant. Methods: We analyzed cross-sectional SARS-CoV-2 seroprevalence data from the Canadian Blood Services serosurveillance program (June 2020 to April 2023) using a previously described dynamic susceptible-infection model, while accounting for seroreversion. Race-specific force of infection was estimated for the pre-Omicron and Omicron periods (with the emergence of Omicron defined as beginning December 26, 2021). Results: Prior to Omicron, racialized individuals had a 74% higher force of infection (IRR = 2.205; 95% CI: 2.115-2.299). During the Omicron period, infection rates rose significantly within each racial group relative to the pre-Omicron period, with a 55.52-fold increase among White individuals and a 31.27-fold increase among racialized individuals. Despite this, racialized individuals remained disproportionately affected following the emergence of Omicron, with 24% higher infection rates than those of their White counterparts (IRR = 1.242; 95% CI: 1.231-1.253). Conclusion: Widespread transmission during Omicron did not result in epidemiologic equity, as racialized populations continued to experience higher infection risk despite crude seroprevalence depicting convergence.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
JAMA Network Open
127 papers in training set
Top 0.1%
18.6%
2
Clinical Infectious Diseases
231 papers in training set
Top 0.5%
8.4%
3
PLOS ONE
4510 papers in training set
Top 25%
6.8%
4
Scientific Reports
3102 papers in training set
Top 19%
6.3%
5
Emerging Infectious Diseases
103 papers in training set
Top 0.4%
4.3%
6
Annals of Internal Medicine
27 papers in training set
Top 0.1%
4.0%
7
PLOS Medicine
98 papers in training set
Top 1%
3.1%
50% of probability mass above
8
eLife
5422 papers in training set
Top 30%
2.9%
9
Nature Communications
4913 papers in training set
Top 44%
2.6%
10
The Journal of Infectious Diseases
182 papers in training set
Top 2%
2.6%
11
Open Forum Infectious Diseases
134 papers in training set
Top 0.7%
2.6%
12
American Journal of Epidemiology
57 papers in training set
Top 0.5%
2.1%
13
PNAS Nexus
147 papers in training set
Top 0.1%
2.1%
14
Viruses
318 papers in training set
Top 2%
1.9%
15
Canadian Medical Association Journal
15 papers in training set
Top 0.1%
1.8%
16
BMC Medicine
163 papers in training set
Top 3%
1.7%
17
BMC Public Health
147 papers in training set
Top 4%
1.5%
18
iScience
1063 papers in training set
Top 22%
1.2%
19
Eurosurveillance
80 papers in training set
Top 1%
1.2%
20
Journal of Racial and Ethnic Health Disparities
11 papers in training set
Top 0.3%
1.2%
21
Journal of Epidemiology and Community Health
32 papers in training set
Top 0.5%
1.1%
22
Science Advances
1098 papers in training set
Top 28%
0.8%
23
eBioMedicine
130 papers in training set
Top 4%
0.7%
24
BMC Infectious Diseases
118 papers in training set
Top 5%
0.7%
25
Journal of Clinical Investigation
164 papers in training set
Top 6%
0.7%
26
Vaccines
196 papers in training set
Top 3%
0.7%
27
Annals of Epidemiology
19 papers in training set
Top 0.8%
0.6%
28
Science Translational Medicine
111 papers in training set
Top 7%
0.6%
29
PeerJ
261 papers in training set
Top 18%
0.6%
30
Journal of Personalized Medicine
28 papers in training set
Top 2%
0.6%